Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.730,00
1,32%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cerecor Inc (CERC) Cerecor Inc (CERC) Notizie

CERC

Cerecor (CERC)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CERC
DataOraFonteTitoloSimboloCompagnia
29/06/202314:23Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CERCCerecor Inc
29/06/202300:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CERCCerecor Inc
28/06/202312:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CERCCerecor Inc
26/06/202313:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CERCCerecor Inc
04/05/202323:12Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CERCCerecor Inc
04/05/202322:06Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CERCCerecor Inc
12/04/202322:01Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:CERCCerecor Inc
29/03/202313:36Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CERCCerecor Inc
13/02/202322:11Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CERCCerecor Inc
03/02/202322:03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CERCCerecor Inc
25/04/202222:05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CERCCerecor Inc
25/04/202222:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CERCCerecor Inc
06/01/202222:17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CERCCerecor Inc
26/08/202113:30GlobeNewswire Inc.Avalo Therapeutics, Inc. Announces Corporate Name Change from Cerecor Inc.NASDAQ:CERCCerecor Inc
02/08/202122:01GlobeNewswire Inc.Cerecor Reports Second Quarter 2021 Financial Results and Provides Business UpdatesNASDAQ:CERCCerecor Inc
02/08/202113:30GlobeNewswire Inc.Cerecor Announces Drawdown of $10 Million Tranche under its Debt Financing Agreement with Horizon Technology FinanceNASDAQ:CERCCerecor Inc
26/07/202122:01GlobeNewswire Inc.Cerecor Announces Positive Initial Phase 1b Results for CERC-002 in Moderate to Severe Crohn's Disease PatientsNASDAQ:CERCCerecor Inc
23/06/202113:30GlobeNewswire Inc.Cerecor Licenses Immune Checkpoint Program from Sanford Burnham Prebys Further Expanding Pipeline of Immunology and Immuno-on...NASDAQ:CERCCerecor Inc
07/06/202113:00GlobeNewswire Inc.Cerecor Enters Into $35 Million Debt Financing Agreement With Horizon Technology FinanceNASDAQ:CERCCerecor Inc
17/05/202113:00GlobeNewswire Inc.Cerecor to Participate in Upcoming Investor ConferencesNASDAQ:CERCCerecor Inc
13/05/202113:00GlobeNewswire Inc.Cerecor Reports First Quarter 2021 Financial Results and Provides Business UpdatesNASDAQ:CERCCerecor Inc
11/05/202113:00GlobeNewswire Inc.FDA Grants Fast Track Designation to CERC-002 for Treatment of Hospitalized Patients with COVID-19NASDAQ:CERCCerecor Inc
29/03/202113:00GlobeNewswire Inc.Cerecor Announces New Worldwide License Agreement with Kyowa Kirin for Anti-LIGHT Antibody CERC-002NASDAQ:CERCCerecor Inc
08/03/202122:01GlobeNewswire Inc.Cerecor Reports 2020 Financial Results and Provides Business UpdatesNASDAQ:CERCCerecor Inc
04/03/202113:00GlobeNewswire Inc.Cerecor to Present at Upcoming Investor ConferencesNASDAQ:CERCCerecor Inc
02/03/202113:00GlobeNewswire Inc.Cerecor Announces CERC-002 Significantly Reduced Respiratory Failure and Mortality in Phase 2 Clinical Trial in Patients Hosp...NASDAQ:CERCCerecor Inc
01/03/202113:00GlobeNewswire Inc.Cerecor Appoints Schond L. Greenway as Chief Financial OfficerNASDAQ:CERCCerecor Inc
02/02/202113:00GlobeNewswire Inc.Cerecor Announces Fast Track Designation for CERC-803 for the Treatment of Leukocyte Adhesion Deficiency Type IINASDAQ:CERCCerecor Inc
20/01/202113:00GlobeNewswire Inc.Cerecor Announces Proceeds from Option to Purchase Additional Shares of Common Stock Bringing Public Offering Proceeds to $40...NASDAQ:CERCCerecor Inc
12/01/202122:01GlobeNewswire Inc.Cerecor Inc. Announces Closing of $36.4 Million Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:CERCCerecor Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CERC

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
TIT
Telecom Italia
BIT
SPM
Saipem
BIT
SRG
Snam
BIT
TEN
Tenaris
BIT
TRN
Terna Trasmissione Elett...
BIT
IVG
Iveco Group NV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network